Both in Pharmaceuticals
Clene vs Rein Therapeutics
Over the past year CLNN returned −62.5% and RNTX returned −53.6%; their daily moves had a correlation of 0.20.
CLNN −62.5% RNTX −53.6%Growth of $1, one year, split-adjusted
| Metric | CLNN | RNTX |
|---|---|---|
| Price | $4.10 | $0.6587 |
| Market cap | $58.3M | $56.8M |
| Today | +8.75% | −1.32% |
| 1 month | +5.9% | −20.2% |
| 6 months | −42.7% | −43.7% |
| Year to date | −30.2% | −43.2% |
| 1 year | −65.8% | −62.4% |
| Revenue growth (YoY) | +233.3% | — |
| Gross margin | 60.0% | — |
| Net margin | −14915.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 295.8× | — |
| Net cash | -$9.1M | $40.6M |
| Dividend yield | — | — |
| Volatility (60d) | 77.9% | 95.8% |
| Short % of float | 4.6% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).